The US Food and Drug Administration reveals it holds out hope for establishing lawful use of hemp ingredients in non-drug products subject to its regulatory oversight by launching another program intended to gather data.
The Cannabis-Derived Products Data Acceleration Plan launched in October, however, could reach the same conclusion the agency has found in...